Antimicrobial peptides: General overview and clinical implications in human health and disease

Clinical Immunology

Volumn 135, Issue 1, 2010, Pages 1-11

  Guaní Guerra, Eduardo ^a   Santos Mendoza, Teresa ^b   Lugo Reyes, Saúl O ^b   Terán, Luis M ^b  

^a Hospital Regional de Alta Especialidad del Bajío León   (Mexico)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Antimicrobial peptides; Cathelicidin; Defensins; Host defense; Innate immunity

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; BETA DEFENSIN 5; BETA DEFENSIN 6; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CYTOKINE; DEFENSIN; DEFENSIN 1; DEFENSIN 2; DEFENSIN 3; HISTATIN; HUMAN DEFENSIN 5; HUMAN DEFENSIN 6; HUMAN NEUTROPHIL PEPTIDE 4; INDOLICIDIN; LACTOFERRICIN; MBI 226; MX 594AN; PG 1; PLECTASIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEGRIN; SARALASIN; UNCLASSIFIED DRUG; VITAMIN D;

ACNE VULGARIS; ANTIBACTERIAL ACTIVITY; ANTIVIRAL ACTIVITY; ATOPIC DERMATITIS; CATHETER INFECTION; DRUG EFFECT; GINGIVITIS; HUMAN; IMMUNOMODULATION; INFECTION; INFLAMMATION; PERITONITIS; PLEIOTROPY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TOOTH PLAQUE;

ANTIMICROBIAL CATIONIC PEPTIDES; CATHELICIDINS; DEFENSINS; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION;

EID: 77649237880     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.12.004     Document Type: Review

References (98)

1. Boman H.G. Innate immunity and the normal microflora. Immunol. Rev. 173 (2000) 5-16
2. Lehrer R.I., and Ganz T. Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 11 (1999) 23-27
3. Lai Y., and Gallo R.L. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 30 (2009) 131-141
4. Bulet P., Stocklin R., and Menin L. Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev. 198 (2004) 169-184
5. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
6. Ganz T. Defensins and host defense. Science 286 (1999) 420-421
7. Yang D., Biragyn A., Kwak L.W., and Oppenheim J.J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23 (2002) 291-296
8. Zaiou M. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J. Mol. Med. 85 (2007) 317-329
9. Zanetti M., Gennaro R., and Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374 (1995) 1-5
10. Cowland J.B., Johnsen A.H., and Borregaard N. hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett. 368 (1995) 173-176
11. Agerberth B., Gunne H., Odeberg J., Kogner P., Boman H.G., and Gudmundsson G.H. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 195-199
12. Frohm M., Agerberth B., Ahangari G., Stahle-Backdahl M., Liden S., Wigzell H., and Gudmundsson G.H. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272 (1997) 15258-15263
13. Sorensen O.E., Follin P., Johnsen A.H., Calafat J., Tjabringa G.S., Hiemstra P.S., and Borregaard N. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97 (2001) 3951-3959
14. Murakami M., Lopez-Garcia B., Braff M., Dorschner R.A., and Gallo R.L. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J. Immunol. 172 (2004) 3070-3077
15. Di Nardo A., Vitiello A., and Gallo R.L. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170 (2003) 2274-2278
16. Zasloff M. Defending the epithelium. Nat. Med. 12 (2006) 607-608
17. Kim S.T., Cha H.E., Kim D.Y., Han G.C., Chung Y.S., Lee Y.J., Hwang Y.J., and Lee H.M. Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease. Acta. Otolaryngol. 123 (2003) 81-85
18. Bals R., Wang X., Zasloff M., and Wilson J.M. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9541-9546
19. Raj P.A., and Dentino A.R. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol. Lett. 206 (2002) 9-18
20. Linzmeier R., Ho C.H., Hoang B.V., and Ganz T. A 450-kb contig of defensin genes on human chromosome 8p23. Gene 233 (1999) 205-211
21. White S.H., Wimley W.C., and Selsted M.E. Structure, function, and membrane integration of defensins. Curr. Opin. Struct. Biol. 5 (1995) 521-527
22. Ouellette A.J. Defensin-mediated innate immunity in the small intestine. Best Pract. Res. Clin. Gastroenterol. 18 (2004) 405-419
23. Quayle A.J., Porter E.M., Nussbaum A.A., Wang Y.M., Brabec C., Yip K.P., and Mok S.C. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am. J. Pathol. 152 (1998) 1247-1258
24. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3 (2003) 710-720
25. Schutte B.C., Mitros J.P., Bartlett J.A., Walters J.D., Jia H.P., Welsh M.J., Casavant T.L., and McCray Jr. P.B. Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2129-2133
26. McCray Jr. P.B., and Bentley L. Human airway epithelia express a beta-defensin. Am. J. Respir. Cell Mol. Biol. 16 (1997) 343-349
27. Valore E.V., Park C.H., Quayle A.J., Wiles K.R., McCray Jr. P.B., and Ganz T. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. 101 (1998) 1633-1642
28. Harder J., Bartels J., Christophers E., and Schroder J.M. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276 (2001) 5707-5713
29. Ghosh S.K., Gerken T.A., Schneider K.M., Feng Z., McCormick T.S., and Weinberg A. Quantification of human beta-defensin-2 and -3 in body fluids: application for studies of innate immunity. Clin. Chem. 53 (2007) 757-765
30. Garcia J.R., Krause A., Schulz S., Rodriguez-Jimenez F.J., Kluver E., Adermann K., Forssmann U., Frimpong-Boateng A., Bals R., and Forssmann W.G. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB. J. 15 (2001) 1819-1821
31. Yamaguchi Y., Nagase T., Makita R., Fukuhara S., Tomita T., Tominaga T., Kurihara H., and Ouchi Y. Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice. J. Immunol. 169 (2002) 2516-2523
32. Tran D., Tran P.A., Tang Y.Q., Yuan J., Cole T., and Selsted M.E. Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides. J. Biol. Chem. 277 (2002) 3079-3084
33. Gombart A.F., Borregaard N., and Koeffler H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 19 (2005) 1067-1077
34. Schauber J., Dorschner R.A., Yamasaki K., Brouha B., and Gallo R.L. Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology 118 (2006) 509-519
35. Schauber J., Svanholm C., Termen S., Iffland K., Menzel T., Scheppach W., Melcher R., Agerberth B., Luhrs H., and Gudmundsson G.H. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut 52 (2003) 735-741
36. Schauber J., Iffland K., Frisch S., Kudlich T., Schmausser B., Eck M., Menzel T., Gostner A., Luhrs H., and Scheppach W. Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells. Mol. Immunol. 41 (2004) 847-854
37. Murakami M., Ohtake T., Dorschner R.A., Schittek B., Garbe C., and Gallo R.L. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J. Invest. Dermatol. 119 (2002) 1090-1095
38. Harder J., Meyer-Hoffert U., Teran L.M., Schwichtenberg L., Bartels J., Maune S., and Schroder J.M. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am. J. Respir. Cell Mol. Biol. 22 (2000) 714-721
39. Mendez-Samperio P., Alba L., and Trejo A. Mycobacterium bovis-mediated induction of human beta-defensin-2 in epithelial cells is controlled by intracellular calcium and p38MAPK. J. Infect. 54 (2007) 469-474
40. Vora P., Youdim A., Thomas L.S., Fukata M., Tesfay S.Y., Lukasek K., Michelsen K.S., Wada A., Hirayama T., Arditi M., and Abreu M.T. Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J. Immunol. 173 (2004) 5398-5405
41. Amlie-Lefond C., Paz D.A., Connelly M.P., Huffnagle G.B., Whelan N.T., and Whelan H.T. Innate immunity for biodefense: a strategy whose time has come. J. Allergy Clin. Immunol. 116 (2005) 1334-1342
42. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., and Sabat R. IL-22 increases the innate immunity of tissues. Immunity 21 (2004) 241-254
43. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., Basham B., Smith K., Chen T., Morel F., Lecron J.C., Kastelein R.A., Cua D.J., McClanahan T.K., Bowman E.P., and de Waal Malefyt R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8 (2007) 950-957
44. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 3 (2005) 238-250
45. Cudic M., and Otvos Jr. L. Intracellular targets of antibacterial peptides. Curr. Drug Targets. 3 (2002) 101-106
46. De Y., Chen Q., Schmidt A.P., Anderson G.M., Wang J.M., Wooters J., Oppenheim J.J., and Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192 (2000) 1069-1074
47. Koczulla R., von Degenfeld G., Kupatt C., Krotz F., Zahler S., Gloe T., Issbrucker K., Unterberger P., Zaiou M., Lebherz C., Karl A., Raake P., Pfosser A., Boekstegers P., Welsch U., Hiemstra P.S., Vogelmeier C., Gallo R.L., Clauss M., and Bals R. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111 (2003) 1665-1672
48. Bowdish D.M., Davidson D.J., Lau Y.E., Lee K., Scott M.G., and Hancock R.E. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 77 (2005) 451-459
49. Niyonsaba F., Someya A., Hirata M., Ogawa H., and Nagaoka I. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur. J. Immunol. 31 (2001) 1066-1075
50. Kirikae T., Hirata M., Yamasu H., Kirikae F., Tamura H., Kayama F., Nakatsuka K., Yokochi T., and Nakano M. Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect. Immun. 66 (1998) 1861-1868
51. Scott M.G., Vreugdenhil A.C., Buurman W.A., Hancock R.E., and Gold M.R. Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J. Immunol. 164 (2000) 549-553
52. Scott M.G., Gold M.R., and Hancock R.E. Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria. Infect. Immun. 67 (1999) 6445-6453
53. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., Anderson M., Schroder J.M., Wang J.M., Howard O.M., and Oppenheim J.J. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286 (1999) 525-528
54. Niyonsaba F., Iwabuchi K., Matsuda H., Ogawa H., and Nagaoka I. Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int. Immunol. 14 (2002) 421-426
55. Niyonsaba F., Ushio H., Nagaoka I., Okumura K., and Ogawa H. The human beta-defensins (-1,-2,-3,-4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J. Immunol. 175 (2005) 1776-1784
56. Niyonsaba F., Ushio H., Nakano N., Ng W., Sayama K., Hashimoto K., Nagaoka I., Okumura K., and Ogawa H. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J. Invest. Dermatol. 127 (2007) 594-604
57. Murphy C.J., Foster B.A., Mannis M.J., Selsted M.E., and Reid T.W. Defensins are mitogenic for epithelial cells and fibroblasts. J. Cell. Physiol. 155 (1993) 408-413
58. Aarbiou J., Verhoosel R.M., Van Wetering S., De Boer W.I., Van Krieken J.H., Litvinov S.V., Rabe K.F., and Hiemstra P.S. Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am. J. Respir. Cell Mol. Biol. 30 (2004) 193-201
59. Davidson D.J., Currie A.J., Reid G.S., Bowdish D.M., MacDonald K.L., Ma R.C., Hancock R.E., and Speert D.P. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 172 (2004) 1146-1156
60. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A.K., Farber J.M., Segal D.M., Oppenheim J.J., and Kwak L.W. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298 (2002) 1025-1029
61. Dorschner R.A., Pestonjamasp V.K., Tamakuwala S., Ohtake T., Rudisill J., Nizet V., Agerberth B., Gudmundsson G.H., and Gallo R.L. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol. 117 (2001) 91-97
62. Raqib R., Sarker P., Bergman P., Ara G., Lindh M., Sack D.A., Nasirul Islam K.M., Gudmundsson G.H., Andersson J., and Agerberth B. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 9178-9183
63. Islam D., Bandholtz L., Nilsson J., Wigzell H., Christensson B., Agerberth B., and Gudmundsson G. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7 (2001) 180-185
64. Klotman M.E., and Chang T.L. Defensins in innate antiviral immunity. Nat. Rev. Immunol. 6 (2006) 447-456
65. Feng Z., Dubyak G.R., Lederman M.M., and Weinberg A. Cutting edge: human beta defensin 3-a novel antagonist of the HIV-1 coreceptor CXCR4. J. Immunol. 177 (2006) 782-786
66. Chen X., Niyonsaba F., Ushio H., Okuda D., Nagaoka I., Ikeda S., Okumura K., and Ogawa H. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J. Dermatol. Sci. 40 (2005) 123-132
67. Aerts A.M., Francois I.E., Cammue B.P., and Thevissen K. The mode of antifungal action of plant, insect and human defensins. Cell. Mol. Life Sci. 65 (2008) 2069-2079
68. Rivas-Santiago B., Schwander S.K., Sarabia C., Diamond G., Klein-Patel M.E., Hernandez-Pando R., Ellner J.J., and Sada E. Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells. Infect. Immun. 73 (2005) 4505-4511
69. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., Gallo R.L., and Leung D.Y. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347 (2002) 1151-1160
70. Gilliet M., and Lande R. Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr. Opin. Immunol. 20 (2008) 401-407
71. Yamasaki K., Di Nardo A., Bardan A., Murakami M., Ohtake T., Coda A., Dorschner R.A., Bonnart C., Descargues P., Hovnanian A., Morhenn V.B., and Gallo R.L. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat. Med. 13 (2007) 975-980
72. Segaert S. Vitamin D regulation of cathelicidin in the skin: toward a renaissance of vitamin D in dermatology?. J. Invest. Dermatol. 128 (2008) 773-775
73. Hata T.R., Kotol P., Jackson M., Nguyen M., Paik A., Udall D., Kanada K., Yamasaki K., Alexandrescu D., and Gallo R.L. Administration of oral vitamin D induces cathelicidin production in atopic individuals. J. Allergy. Clin. Immunol. 122 (2008) 829-831
74. Hiemstra P.S. Defensins and cathelicidins in inflammatory lung disease: beyond antimicrobial activity. Biochem. Soc. Trans. 34 (2006) 276-278
75. Bals R., Wang X., Wu Z., Freeman T., Bafna V., Zasloff M., and Wilson J.M. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Invest. 102 (1998) 874-880
76. Beisswenger C., and Bals R. Antimicrobial peptides in lung inflammation. Chem. Immunol. Allergy 86 (2005) 55-71
77. Mukae H., Ishimoto H., Yanagi S., Ishii H., Nakayama S., Ashitani J., Nakazato M., and Kohno S. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis. Respir. Med. 101 (2007) 715-721
78. Lee S.H., Lim H.H., Lee H.M., and Choi J.O. Expression of human beta-defensin 1 mRNA in human nasal mucosa. Acta Otolaryngol. 120 (2000) 58-61
79. Meyer J.E., Harder J., Gorogh T., Schroder J.M., and Maune S. hBD-2 gene expression in nasal mucosa. Laryngorhinootologie 79 (2000) 400-403
80. Vanhinsbergh L.J., Powe D.G., and Jones N.S. Reduction of TLR2 gene expression in allergic and nonallergic rhinitis. Ann. Allergy Asthma Immun. 99 (2007) 509-516
81. Richer S.L., Truong-Tran A.Q., Conley D.B., Carter R., Vermylen D., Grammer L.C., Peters A.T., Chandra R.K., Harris K.E., Kern R.C., and Schleimer R.P. Epithelial genes in chronic rhinosinusitis with and without nasal polyps. Am. J. Rhinol. 22 (2008) 228-234
82. Bryborn M., Adner M., and Cardell L.O. Psoriasin, one of several new proteins identified in nasal lavage fluid from allergic and non-allergic individuals using 2-dimensional gel electrophoresis and mass spectrometry. Respir. Res. 6 (2005) 118
83. Herr C., Beisswenger C., Hess C., Kandler K., Suttorp N., Welte T., Schroeder J.M., and Vogelmeier C. Suppression of pulmonary innate host defence in smokers. Thorax 64 (2009) 144-149
84. Fellermann K., Stange D.E., Schaeffeler E., Schmalzl H., Wehkamp J., Bevins C.L., Reinisch W., Teml A., Schwab M., Lichter P., Radlwimmer B., and Stange E.F. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am. J. Hum. Genet. 79 (2006) 439-448
85. Wehkamp J., Wang G., Kubler I., Nuding S., Gregorieff A., Schnabel A., Kays R.J., Fellermann K., Burk O., Schwab M., Clevers H., Bevins C.L., and Stange E.F. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J. Immunol. 179 (2007) 3109-3118
86. Wehkamp J., Schmid M., and Stange E.F. Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr. Opin. Gastroenterol. 23 (2007) 370-378
87. Hoskin D.W., and Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta 1778 (2008) 357-375
88. Baroni A., Donnarumma G., Paoletti I., Longanesi-Cattani I., Bifulco K., Tufano M.A., and Carriero M.V. Antimicrobial human beta-defensin-2 stimulates migration, proliferation and tube formation of human umbilical vein endothelial cells. Peptides 30 (2009) 267-272
89. Higazi A.A., Lavi E., Bdeir K., Ulrich A.M., Jamieson D.G., Rader D.J., Usher D.C., Kane W., Ganz T., and Cines D.B. Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells. Blood 89 (1997) 4290-4298
90. Barnathan E.S., Raghunath P.N., Tomaszewski J.E., Ganz T., Cines D.B., and Higazi A.a.-R. Immunohistochemical localization of defensin in human coronary vessels. Am. J. Pathol. 150 (1997) 1009-1020
91. Higazi A.A., Nassar T., Ganz T., Rader D.J., Udassin R., Bdeir K., Hiss E., Sachais B.S., Williams K.J., Leitersdorf E., and Cines D.B. The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis. Blood 96 (2000) 1393-1398
92. Higazi A.A., Ganz T., Kariko K., and Cines D.B. Defensin modulates tissue-type plasminogen activator and plasminogen binding to fibrin and endothelial cells. J. Biol. Chem. 271 (1996) 17650-17655
93. Kougias P., Chai H., Lin P.H., Yao Q., Lumsden A.B., and Chen C. Neutrophil antimicrobial peptide alpha-defensin causes endothelial dysfunction in porcine coronary arteries. J. Vasc. Surg. 43 (2006) 357-363
94. Liu Y., Yu H., Zhang Y., and Zhao Y. TLRs are important inflammatory factors in atherosclerosis and may be a therapeutic target. Med. Hypotheses 70 (2008) 314-316
95. Joseph G., Tarnow L., Astrup A.S., Hansen T.K., Parving H.H., Flyvbjerg A., and Frystyk J. Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patients. J. Clin. Endocrinol. Metab. 93 (2008) 1470-1475
96. Marr A.K., Gooderham W.J., and Hancock R.E. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6 (2006) 468-472
97. Bals R., Weiner D.J., Meegalla R.L., and Wilson J.M. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J. Clin. Invest. 103 (1999) 1113-1117
98. Jacobsen F., Mittler D., Hirsch T., Gerhards A., Lehnhardt M., Voss B., Steinau H.U., and Steinstraesser L. Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections. Gene Ther. 12 (2005) 1494-1502